A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...

Guselkumab improves scalp psoriasis and quality of life in patients with skin of color.

From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.

Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of Dermatology/National Psoriasis ...

Dallas art exhibit honors untold stories of African American veterans A life of service is never easy, and for many men and women of color who serve in the military, the challenges can be even ...

Psoriasis is caused by a faulty immune system. Treatments include topical medicines, light therapy, systemic drugs like biologics, and home remedies.

For Black Americans with scalp psoriasis, especially women, this can be problematic, as their hair dries out quickly if washed too often.

Despite the uphill battle to pass federal reparations bills for African Americans, some lawmakers continue to reintroduce the measures.

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

Canceled grants and the administration’s prolonged attack on diversity efforts have dampened museum visits and threatened some groups’ survival.

It can be hard to find out what your body needs when you're looking to relieve a psoriasis flare. Learn what your body is trying to tell you and how to respond.